RecruitingPhase 1NCT07471516
Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia
Studying Congenital dyserythropoietic anemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Principal Investigator
- Xin Zhao, MD, MD
- Intervention
- zoledronic acid(drug)
- Enrollment
- 2 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Institute of Hematology & Blood Diseases Hospital, Tianjin, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07471516 on ClinicalTrials.govOther trials for Congenital dyserythropoietic anemia
Additional recruiting or active studies for the same condition.